ALGS

Conviction 42HealthcareScan · Mon, Aug 10, 2026

Bullish marubozu

ALGS$7.62+36.31%

ResistanceSupportVol 14

Vol MA14 360.85K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Aligos Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.aligos.com ↗

Price7.62

Change+36.31%

Gap+3.22%

Rel volume26.52×

Avg volume273.34K

Avg $ vol1.78M

SMA 205.10

SMA 505.38

SMA 2007.25

Price vs 50+41.73%

Price vs 200+5.11%

MA stackmixed

50/200 cross—

Supertrendup · 4.62

RSI (14)75

MACD hist0.27

MACD crossbull · 2d

Stoch %K / %D98 / 85

ADX (14)24

+DI / −DI39 / 11

RSI divergence—

MACD divergence—

ATR %+8.40%

ADR %10.72%

52w high13.30

52w low4.08

From 52w high-42.69%

Above 52w low+86.76%

New 52w highNo

SqueezeOff

Bollinger width67.42%

%B1.23

Donchian pos97.98%

Donchian high7.70

Donchian low3.98

AVWAP (52w high)6.83

vs AVWAP high+11.56%

AVWAP (52w low)6.35

vs AVWAP low+19.92%

OBV trendUp

Chaikin MF (20)0.48

Today vs 20d26.52×

Avg vol (14d)360.85K

Avg vol (20d)273.34K

Avg $ vol (20d)1.78M

Market cap324.68M

RS 3m (vs SPY)-12.99%

RS 6m (vs SPY)-27.98%

RS line new highNo

Trend template3/8

Technical rank71.2

1 week+65.65%

1 month+15.11%

3 months+18.32%

6 months+4.10%

1 year-6.27%

YTD-16.54%

P/E-13.42

P/B10.18

P/S148.53

P/FCF-3.93

EPS-2.45

Div yield—

ROE-75.88%

ROA-36.48%

Debt/Eq—

Current2.19

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-39.46%

EPS growth81.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value294.3M

Revenue0

Net income-1.5M

Gross profit—

Free cash flow-82.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out5.39M

Employees82

ListedFri, Oct 16, 2020

Free float4.81M

Float %89.2%

Short interest521.42K

Days to cover1.0d

Short volume48.8%

Squeeze score48 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.14 vs −$1.41

Last surprise+90.1% beat

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank71.2 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALGS

All disclosures →

No recent disclosed trades by Congress in ALGS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALGS · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Hirth Peter Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29
Chavez Margarita Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29
Nuechterlein Carole Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29
Scopa James Paul Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29
Martell Bridget A Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29
Preston Heather Director · Stock Option (Right to Buy) · 2026-06-25	Grant	5.86K	—	2026-06-25	2026-06-29

SEC filings

EDGAR filings in ALGS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.